Citation Impact
Citing Papers
Comprehensive computational design of ordered peptide macrocycles
2017 StandoutScienceNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
In Situ One‐Pot Synthesis of MOF–Polydopamine Hybrid Nanogels with Enhanced Photothermal Effect for Targeted Cancer Therapy
2018
Hallmarks of Cancer: The Next Generation
2011 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Tumor-targeting peptides from combinatorial libraries
2016
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Lung Cancer
2008 Standout
Therapies directed at vascular endothelial growth factor
2002
Angiogenesis and antiangiogenic therapy in hematologic malignancies
2006
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
The biology of VEGF and its receptors
2003 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Multilayer Microcapsules as Anti‐Cancer Drug Delivery Vehicle: Deposition, Sustained Release, and in vitro Bioactivity
2005
Anti-angiogenic activity of inositol hexaphosphate (IP6)
2004
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Putting tumours in context
2001 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Nanotheranostics for personalized medicine
2012
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Biology and management of relapsed acute myeloid leukaemia
2005
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
The role of VEGF in normal and neoplastic hematopoiesis
2002
A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
2013
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
2005 StandoutNobel
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Targeting endothelial and tumor cells with semaphorins
2007
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Tumor Angiogenesis
2008 Standout
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
2008
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Targeting of drugs and nanoparticles to tumors
2010
Superparamagnetic Iron Oxide Nanoparticles in Biomedicine: Applications and Developments in Diagnostics and Therapy
2013
Acute Myeloid Leukemia
2015 Standout
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Acute Myeloid Leukemia and Acute Promyelocytic Leukemia
2003
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias
2001
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Hybridization of Emerging Crystalline Porous Materials: Synthesis Dimensionality and Electrochemical Energy Storage Application
2021 StandoutNobel
How I treat refractory and early relapsed acute myeloid leukemia
2015
Nanotheranostics for personalized medicine.
2012
Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia
2005
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease
2005
Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti–vascular endothelial growth factor receptor therapy
2002
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm
2002
Hollow Micro‐/Nanostructures: Synthesis and Applications
2008 Standout
Cancer Genome Landscapes
2013 StandoutScience
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
2003
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Combinatorial Peptide Libraries: Mining for Cell-Binding Peptides
2013
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies
2002
Nanoparticles that communicate in vivo to amplify tumour targeting
2010
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Ralf Bieker being referenced
Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.
2003
Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia
2006
Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
2007
Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
2008
Antiangiogenic Tumor Treatment: Early Noninvasive Monitoring with USPIO-enhanced MR Imaging in Mice
2007
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia
2002
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
2000
Expression of Angiopoietins and Their Receptor Tie2 in the Bone Marrow of Patients with Acute Myeloid Leukemia.
2006
Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia
2001
Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience
2009
Efficacy and safety of thalidomide in patients with acute myeloid leukemia
2002
Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
2006
Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia
2003
Inhibition of Tumor Growth by RGD Peptide–Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature
2005